RetroSense Therapeutics Begins Clinical Trials For Drug To Restore Vision
ANN ARBOR - RetroSense Therapeutics, a privately-held biopharmaceutical company, announced Monday the first patient has been successfully dosed in the first clinical trial to evaluate the safety of of a drug to restore some vision for people suffering from Retinitis Pigmentosa, which can result in vision loss and blindness. “Successfully dosing our first patient with









